There is a move towards personalised medicines particularly in the treatment of unmet medical needs, however, currently available dosage forms and manufacturing procedures are not suited for the ...
(RTTNews) - Clearmind Medicine Inc. (CMND), Wednesday announced that the company has signed a non-binding Letter of Intent with Polyrizon Ltd. (PLRZ), a development stage biotech company, to ...
About Bio-Convert Bio-Convert’s mission is to develop the preferred treatment for oral leukoplakia. Our innovative therapeutic agent, QR-02, uses a novel drug delivery technology, that enables more ...
The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).
11 天
Onlymyhealth on MSNRenogrit: Patanjali’s Ayurvedic Breakthrough Recognised Among Top 100 Research Papers ...Ayurveda, a centuries-old practice, has been an important part of traditional medicine in India, offering holistic healing ...
In the vast realm of traditional Chinese medicine (TCM), there are countless formulations that have stood the test of time, proving their efficacy and value across centuries. One such formulation ...
Enables women to access a solution that they want and need Creates an opportunity to accelerate revenue generation from this proprietary ...
SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel curcumin transdermal formulation developed by Vascarta Inc.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果